Author

K.-C. Kim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

J.-S. Yang· 3 shared J.-Y. Lee· 3 shared J. Cho· 2 shared J. W. Kim· 2 shared B. Kang· 1 shared C. Kim· 1 shared D.-K. Ryu· 1 shared H. Lee· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

J.-S. Yang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron variants

J. Cho, Y. Shin, J.-S. Yang, J. W. Kim, K.-C. Kim, J.-Y. Lee

This study evaluates the antiviral efficacy of remdesivir, molnupiravir, and nirmatrelvir against newly emerged SARS-CoV-2 Omicron subvariants and finds they retain antiviral activity.

bioRxiv · Mar 26, 2023Microbiology

Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells

T. Kim, K. I. Min, J.-S. Yang, J. W. Kim, J. Cho, Y. H. Kim, J. S. Lee, Y. T. Kim, K.-C. Kim, J. Y. Kim, K. J. Na, J.-Y. Lee, Y. S. Ju

This study compares the infectivity of SARS-CoV-2 variants in human alveolar cells, finding Omicron (BA.1) to be 3-5-fold more infectious than other variants at early infection.

bioRxiv · Apr 13, 2022Microbiology

The in vitro and in vivo potency of CT-P59 against Delta and its associated variants of SARS-CoV-2

D.-K. Ryu, H.-M. Woo, B. Kang, H. Noh, J.-I. Kim, J.-M. Seo, C. Kim, M. Kim, J.-W. Kim, N. Kim, P. Jeon, H. Lee, J.-S. Yang, K.-C. Kim, J.-Y. Lee, , S.-Y. Lee

This study evaluates CT-P59's antiviral activity against Delta and its variants, showing reduced in vitro potency but effective in vivo neutralization and symptom remission in mice.

bioRxiv · Jul 23, 2021 · PreprintMicrobiology